Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors

Journal of Clinical Oncology

Volumn 14, Issue 6, 1996, Pages 1829-1838

  Taal, B G ^a   Hoefnagel, C A ^a   Valdes Olmos, R A ^a   Boot, H ^a   Beijnen, J H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; DOXORUBICIN; FLUOROURACIL; GAMMA INTERFERON; NIFEDIPINE; SOMATOSTATIN; STREPTOZOCIN;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CARCINOID; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; HYPERTENSION; INFLUENZA; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION PROCEDURE; MALE; PRIORITY JOURNAL; STEATORRHEA; TREATMENT OUTCOME;

EID: 0029967356     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.6.1829     Document Type: Article

References (23)

1. Moertel CG: An odyssey in the land of small tumors. J Clin Oncol 5:1503-1522, 1987
2. Oberg K: Treatment of neuroendocrine tumors. Cancer Treat Rev 20:331-355, 1994
3. Kvols LK, Moertel CG, O'Connell MJ, et al: Treatment of the malignant carcinoid syndrome: Evaluation of a long-acting somatostatin analogue. N Engl J Med 315:663-666, 1986
4. Lamberts SWJ, Reubi J-P, Krenning EP: The role of somatostatin analogs in the control of tumor growth. Semin Oncol 5:61-64, 1994 (suppl 13)
5. 3)-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:283-292, 1993
6. Oberg K, Funa K, Alm G: Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. N Engl J Med 309:129-133, 1983
7. Moertel CG, Rubin J, Kvols LK: Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 7:865-868, 1989
8. Biesma B, Willemse PHB, Mulder NH, et al: Recombinant interferon alpha-2b in patients with metastatic apudomas: Effect on tumours and tumour markers. Br J Cancer 66:850-855, 1992
9. Veenhof CHN, de Wit R, Taal BG, et al: A dose escalating study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour. Eur J Cancer 28:75-78, 1992
10. Hoefnagel CA, den Hartog Jager FCA, van Gennip AH, et al: Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzyl-guanidine. Clin Nucl Med 11:150-152, 1986
11. Hoefnagel CA, den Hartog Jager FCA, Taal BG, et al: The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med 13:187-191, 1987
12. Troncone L, Rufini V, Montemaggi P, et al: The diagnostic and therapeutic utility of radiolabelled metaiodobenzylguanidine (MIBG): 5 years of experience. Eur J Nucl Med 16:325-335, 1990
13. 131I-metaiodobenzylguanidine therapy in carcinoids. J Nucl Biol Med 35:346-348, 1991
14. Hoefnagel CA: Metaiodobenzylguanidine and somatostatin in oncology: Role in the management of neural crest tumours. Eur J Nucl Med 21:561-581, 1994
15. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients. Nucl Med Commun 15:712-717, 1994
16. Smets LA, Bout B, Wisse J: Cytotoxic and antitumour effects of the norepinephrine analogue meta-iodobenzylguanidine (MIBG). Cancer Chemother Pharmacol 21:9-13, 1988
17. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48 Neoplasma 20:37-46, 1980
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
19. Wafelman AR: Pharmaceutical characteristics and pharmacokinetics in cancer patients of iodine-131 labelled meat-iodobenzyl-guanidine and unlabelled meta-iodobenzylguanidine. Thesis, University of Utrecht, Utrecht, the Netherlands, 1994
20. 131I iodobenzylguanidine. J Nucl Med 21:349-353, 1980
21. Tiensuu Janson EM, Ahlstrom H, Andersson T, et al: Octreotide and interferon alpha: A new combination for the treatment of malignant carcinoid tumours. Eur J Cancer 28A:1647-1650, 1992
22. Engstrom PF, Lavin PT, Moertel CG, et al: Streptozotocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 2:1255-1259, 1984
23. Tiensuu Janson E, Ronnblom L, Ahlstrom H, et al: Treatment with alpha-interferon versus alpha-interferon in combination with Streptozotocin and doxorubicin in patients with malignant tumors: A randomized trial. Ann Oncol 3:635-638, 1992